Joinn Laboratories(China)Co.,Ltd. (SHA:603127)

SHA:603127 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,838	2,018	2,376	2,268	1,517	1,076
Revenue	1,838	2,018	2,376	2,268	1,517	1,076
Revenue Growth (YoY)	-16.99%	-15.07%	4.78%	49.54%	40.97%	68.27%
Cost of Revenue	1,424	1,498	1,395	1,187	778.89	524.6
Gross Profit	413.19	520.82	981.55	1,081	737.79	551.3
Selling, General & Admin	297.66	317.06	304.87	317.88	272.13	221.54
Research & Development	88.52	92.92	96.85	77.99	47.76	50.66
Other Operating Expenses	16.38	8.22	-3.32	-22.84	1.26	0.66
Operating Expenses	408.15	437.12	408.4	373.02	321.97	270.11
Operating Income	5.05	83.69	573.16	708.41	415.82	281.2
Interest Expense	-1.98	-2.45	-3.14	-3.58	-3.96	-0.84
Interest & Investment Income	104.05	139.24	152.13	131.23	100.72	3.6
Earnings From Equity Investments	-	-	-	-2.69	-	-
Currency Exchange Gain (Loss)	-3.46	-0.68	12.11	27.4	-60.33	-3.38
Other Non Operating Income (Expenses)	-24.34	-14.13	-0.71	-	-0.76	-0.37
EBT Excluding Unusual Items	79.32	205.68	733.54	860.77	451.5	280.22
Gain (Loss) on Sale of Investments	237.16	-127.05	-245.64	32.21	157.78	58.95
Gain (Loss) on Sale of Assets	0.45	-0.21	-0.25	-0.41	-0.41	-0.31
Asset Writedown	-	-	-	333.07	-	-
Other Unusual Items	44.57	25.62	19.3	14.37	33.14	21.72
Pretax Income	361.51	104.04	506.95	1,240	642	360.57
Income Tax Expense	58.58	34.28	115.4	166.8	85.59	46.94
Earnings From Continuing Operations	302.93	69.76	391.55	1,073	556.42	313.63
Minority Interest in Earnings	1.82	4.32	5.44	1.06	1.04	1.39
Net Income	304.75	74.08	396.99	1,074	557.46	315.01
Net Income to Common	304.75	74.08	396.99	1,074	557.46	315.01
Net Income Growth	123.06%	-81.34%	-63.04%	92.71%	76.96%	68.67%
Shares Outstanding (Basic)	753	741	749	747	723	617
Shares Outstanding (Diluted)	753	741	749	751	729	624
Shares Change (YoY)	1.64%	-1.11%	-0.33%	3.03%	16.95%	1.01%
EPS (Basic)	0.40	0.10	0.53	1.44	0.77	0.51
EPS (Diluted)	0.40	0.10	0.53	1.43	0.76	0.51
EPS Growth	119.46%	-81.13%	-62.94%	87.10%	51.32%	66.97%
Free Cash Flow	115.32	69.54	430.15	676.68	448.41	279.41
Free Cash Flow Per Share	0.15	0.09	0.57	0.90	0.61	0.45
Dividend Per Share	0.030	0.030	0.160	0.286	0.184	0.128
Dividend Growth	-81.25%	-81.25%	-44.00%	55.61%	43.89%	44.18%
Gross Margin	22.49%	25.80%	41.30%	47.68%	48.64%	51.24%
Operating Margin	0.27%	4.15%	24.12%	31.24%	27.42%	26.14%
Profit Margin	16.59%	3.67%	16.71%	47.37%	36.75%	29.28%
Free Cash Flow Margin	6.28%	3.45%	18.10%	29.84%	29.57%	25.97%
EBITDA	100.93	179.58	676.51	802.6	490.27	341.85
EBITDA Margin	5.49%	8.90%	28.47%	35.39%	32.32%	31.77%
D&A For EBITDA	95.89	95.89	103.36	94.19	74.45	60.65
EBIT	5.05	83.69	573.16	708.41	415.82	281.2
EBIT Margin	0.27%	4.15%	24.12%	31.24%	27.42%	26.14%
Effective Tax Rate	16.20%	32.95%	22.76%	13.45%	13.33%	13.02%
Revenue as Reported	1,838	2,018	2,376	-	1,517	1,076
Advertising Expenses	-	5	4.51	-	1.42	1.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.